p63 is a member of the p53 gene family, which consists of 15 exons, and contains two transcriptional start sites, a 5′ promoter that precedes the first exon encoding the full transactivation domain (TAD) on the N-terminus, and a cryptic 3′ intronic promoter that gives rise to ΔN isoforms lacking a full TAD. Both TA and ΔN isotypes can undergo alternative splicing to generate different carboxy-termini (*α*, *β*, *γ*), thus giving rise to at least six different p63 isoforms (TA*α*, TA*β*, TA*γ* and ΔN*α*, ΔN*β*, ΔN*γ*). Each p63 isoform possesses a DNA-binding domain and an oligomerization domain. In addition, p63*α* contains a full-length C-terminus, which consists of a sterile alpha motif (SAM) for protein--protein interaction and a trans-inhibitory domain (TID), whereas p63*β* and p63*γ* isoforms have truncated C-termini due to alternative splicing.^[@bib1],\ [@bib2]^

The TAp63 isoforms are potent transactivators of a subset of genes, which in part overlap with p53 downstream targets including Bax, Puma, and p21. Consequently, TAp63s can induce both cell cycle arrest and apoptosis. By contrast, ΔNp63 isoforms can also transactivate a subset of genes involved in a variety of biological activities. Importantly, ΔNp63*α* has been shown to repress transcriptional activity of p53 family members, enabling ΔNp63*α* to promote cell proliferation and tumorigenesis under certain circumstances.^[@bib2]^

Pin1 is a ubiquitously expressed peptidyl-prolyl isomerase, consisting of an N-terminal WW domain and a C-terminal PPIase domain. The WW domain functions as the specific binding domain for Pin1 substrates and selectively binds to phospho-Ser-Pro (pSP) or phospho-Thr-Pro (pTP) motifs.^[@bib3]^ Point mutations in the WW domain (W34A, Y23A) of Pin1 abolish the protein--protein interaction between Pin1 and its substrates. After binding to its substrates, Pin1 can facilitate the *cis-trans* isomerization of pSP/pTP peptidyl-prolyl bonds through its PPIase domain, resulting in conformational and functional changes of substrate proteins.^[@bib4]^ It is well documented that Pin1 has important roles in diverse cellular processes, and is overexpressed in diverse human tumors and promotes oncogenesis by modulating numerous proteins involved in tumorigenesis.^[@bib5],\ [@bib6],\ [@bib7]^

Although the association between p63 and Pin1 has been previously reported, the underlying mechanism and physiological effects of this physical interaction remain largely unclear.^[@bib8]^ In this study, we demonstrate that Pin1 binds to TAp63*α* and protects it from proteasomal degradation, leading to increased apoptosis. On the other hand, Pin1 can also bind to ΔNp63*α* and inhibits its degradation. Knockdown of Pin1 in FaDu cells lead to a decrease in ΔNp63*α* protein levels and an inhibition of cell proliferation. Our study reveals a mechanism enabling Pin1 to modulate specific p63 isoforms to regulate cell survival/proliferation and tumorigenesis.

Results
=======

Pin1 interacts with p63 *in vitro* and *in vivo*
------------------------------------------------

Pin1 has been shown to physically interact with p53 and p73.^[@bib9],\ [@bib10],\ [@bib11]^ To test if it can bind to p63 proteins, we performed GST--Pin1 pull-down experiment. Our results showed that TAp63*α* ([Figure 1a](#fig1){ref-type="fig"}) TAp63*γ* ([Figure 1b](#fig1){ref-type="fig"}) and ΔNp63 proteins ([Figure 1c](#fig1){ref-type="fig"}) were readily pulled down with GST--Pin1, but not with GST alone.

It was reported that the physical interactions between Pin1 and its substrates is mediated by the WW domain, but not the PPIase domain of Pin1. Point mutations in the WW domain (Y23A or W34A) completely abolish the interaction between Pin1 and its substrates.^[@bib4]^ As shown in [Figure 1d](#fig1){ref-type="fig"}, TAp63*α* bound to the full length or the WW domain of Pin1, but not the PPIase domain, Pin1(W34A), or Pin1(Y23A). In addition, our results of GST--Pin1 pull-down experiment in combination with calf intestine phosphatase and phosphatase inhibitor treatment showed that the interaction between p63 and Pin1 was dependent on p63 phosphorylation ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}).

Next, we further examined whether p63 proteins could physiologically interact with Pin1. As shown in [Figure 1e](#fig1){ref-type="fig"}, TAp63*α* formed a stable complex with Pin1, but not with Pin1(W34A), in transiently transfected H1299 cells. To examine the *in vivo* interaction between Pin1 and ΔNp63*α,* we performed immunoprecipitation using lysate of the head and neck squamous cell carcinoma (HNSCC) cell line FaDu, which expresses high levels of endogenous Pin1 and ΔNp63*α*. As shown in [Figure 1f](#fig1){ref-type="fig"}, endogenous Pin1 and ΔNp63*α* form a stable complex in FaDu cells.

Taken together, our data demonstrate that p63 proteins, including TAp63*α*, TAp63*γ*, ΔNp63*α,* and ΔNp63*γ*,can interact with Pin1, whereas W34 and Y23 in the WW domain of Pin1 are critical for its interaction with p63 proteins.

Pin1 specifically stabilizes p63*α*,but not p63*γ*
--------------------------------------------------

Since Pin1 was reported to stabilize p73 proteins,^[@bib9]^ we asked if Pin1 is involved in regulating p63 protein stability. To this end, we transiently co-expressed TAp63*α* and Pin1 in H1299 cells. The results of immunoblotting showed that expression of wild-type Pin1, but not Pin1(W34A), led to increased TAp63*α* protein levels; as a control of transfection efficiency, GFP protein levels were not affected ([Figure 2a](#fig2){ref-type="fig"}). In addition, we found that transient expression of Pin1, but not Pin1 (W34A), in HEK293 cell line stably overexpressing ΔNp63*α* (HEK293:ΔNp63*α*), upregulates the protein level of ΔNp63*α* ([Figure 2b](#fig2){ref-type="fig"}).

To further investigate Pin1--p63 interaction, we generated H1299 cells stably expressing wild-type Pin1 (H1299:Pin1) or W34A mutant Pin1 \[H1299:Pin1(W34A)\], which cannot interact with p63. As shown in the bottom panel of [Figure 2c](#fig2){ref-type="fig"}, these two stable cell lines express comparable levels of exogenous wild-type or W34A mutant Pin1. After transfection with p63*α* or p63*γ* expression plasmids, H1299:Pin1 cells yielded much higher levels of TAp63*α* or ΔNp63*α* than H1299:Pin1(W34A) cells did ([Figures 2c and d](#fig2){ref-type="fig"}, lane 2 *versus* lane 1), while TAp63*γ* or ΔNp63*γ* protein levels in both cell lines were comparable ([Figures 2c and d](#fig2){ref-type="fig"}, lane 4 *versus* lane 3); as a control, protein levels of GFP were shown in different transfections.

We next knocked down endogenous Pin1 using Pin1-specific siRNA. As shown in [Figure 2e](#fig2){ref-type="fig"}, siRNA-mediated knockdown of Pin1 in HEK293:ΔNp63*α* cells significantly downregulated ΔNp63*α*; Pin1 knockdown in H1299 cells also significantly reduced TAp63*α* and ΔNp63*α*, but not TAp63*γ* ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). Given that the p63 and GFP expression plasmids used in our experiments were driven by the same CMV promoters, these data suggest that Pin1 likely upregulates TAp63*α* and ΔNp63*α* at post-transcriptional levels.

To examine whether Pin1 affects p63 protein stability, we measured the half-life of TAp63*α* protein in H1299 cells by means of cycloheximide (CHX) treatment. As shown in [Figures 2f and g](#fig2){ref-type="fig"}, Pin1 extended the half-life of TAp63*α* protein from 1.2 h to 2.2 h; by contrast, the stability of GFP was not significantly affected by Pin1 under similar settings. Data from subsequent experiments with stable H1299 cell lines expressing wild-type or W34A mutant Pin1 showed that TAp63*α* has a longer half-life in H1299:Pin1 cells than in H1299:Pin1(W34A) cells ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). With HEK293:ΔNp63*α* stable cells, we found that Pin1 extended the half-life of stably expressed ΔNp63*α* from about 4 h to approximately 7 h ([Figures 2h and i](#fig2){ref-type="fig"}). Taken together, these data suggest that Pin1 binds to and stabilizes p63*α* proteins.

T538 is critical for Pin1-mediated TAp63*α* protein stabilization
-----------------------------------------------------------------

Since Pin1 stabilizes p63*α*, but not p63*γ* proteins, we speculated that some regions unique to p63*α* are required for Pin1 effect on p63*α*. As depicted in [Figure 3a](#fig3){ref-type="fig"}, p63*α* isoforms possess a unique C-terminal domain, containing six putative Pin1-binding motifs, which are absent in the alternatively spliced p63*γ* isoforms; among these six Ser/Thr-Pro motifs, T~538~-Pro is adjacent to the P~540~PxY~543~ motif, which was reported as the binding site for ubiquitin E3 ligase WWP1.^[@bib12]^ To identify which site is critical for Pin1-mediated stabilization of TAp63*α*, several single point mutations of TAp63*α*, including S463A, T491A, T538A, and T619A, were constructed. Wild-type TAp63*α* or mutant derivatives were transiently co-transfected into H1299:Pin1 or H1299:Pin1(W34A) cells. As shown in [Figure 3b](#fig3){ref-type="fig"}, wild-type TAp63*α* was significantly upregulated by wild-type Pin1; T538A, but not other point mutations, abolished the Pin1-mediated upregulation of TAp63*α*.

To confirm the importance of T~538~ in Pin1-mediated regulation of TAp63*α*, we examined the protein levels of TAp63*α*(T538A) in H1299 cells in which Pin1 was simultaneously knocked down with specific siRNA. As shown in [Figure 3c](#fig3){ref-type="fig"}, knockdown of Pin1 led to downregulation of wild-type TAp63*α*, but not TAp63*α* (T538A).

These data suggest that T~538~P, which is adjacent to a P~540~PxY~543~ motif, is involved in Pin1-mediated regulation of TAp63*α* stabilization.

Pin1 inhibits WWP1-dependent degradation of p63*α* proteins
-----------------------------------------------------------

To investigate whether proteasome-dependent protein degradation is involved in Pin1-mediated upregulation of p63*α* proteins, we treated cells with a specific proteasome inhibitor MG132 or the vehicle control, DMSO. As shown in [Figure 4a](#fig4){ref-type="fig"}, wild-type Pin1, but not Pin1(W34A), increased TAp63*α* protein levels (lane 2 *versus* lane 1); protein levels of TAp63*α* in MG132 treated cells were much higher than in DMSO controls (lane 3 *versus* lane 1, lane 4 *versus* lane 2); however, Pin1 failed to further increase TAp63*α* protein levels in the presence of MG132 (lane 4 *versus* lane 3). In addition, MG132 was able to reverse the reduction in TAp63*α* protein levels following Pin1 knockdown ([Figure 4b](#fig4){ref-type="fig"}). However, the transfection control GFP, which is not targeted for proteasomal degradation,^[@bib13]^ was not affected by MG132 treatment and Pin1 expression. These data suggest that Pin1 inhibits proteasome-mediated degradation of p63*α* proteins.

WWP1 has been reported to function as a ubiquitin E3 ligase that promotes proteasome-dependent degradation of p63*α* proteins.^[@bib12]^ Our above-mentioned data indicate that Thr~538~-Pro, which is adjacent to the WWP1 binding site (PPxY motif), is critical to Pin1-mediated regulation of p63*α* stability ([Figure 3](#fig3){ref-type="fig"}). As shown in [Figure 4c](#fig4){ref-type="fig"}, overexpression of WWP1 led to a significant decrease in TAp63*α*, which was prevented by co-expression of wild-type Pin1, but not Pin1(W34A). Similarly, Pin1 also significantly inhibited WWP1-mediated downregulation of ΔNp63*α* ([Figure 4d](#fig4){ref-type="fig"}). As shown in [Figure 4e](#fig4){ref-type="fig"}, knockdown of WWP1 increased TAp63*α*, whereas knockdown of Pin1 led to decrease in TAp63*α*; simultaneous knockdown of WWP1 abolished the downregulation of TAp63*α* mediated by Pin1 knockdown. These data suggest that Pin1 is involved in WWP1-mediated degradation of p63*α.*

Since we have shown that T538 is critical for Pin1-mediated TAp63*α* stabilization ([Figures 3b and c](#fig3){ref-type="fig"}), we next investigated the effect of WWP1 on TAp63*α*(T538A) protein stability. As shown in [Figure 4f](#fig4){ref-type="fig"}, WWP1 also decreased protein levels of TAp63*α*(T538A), suggesting that T538A substitution does not affect WWP1-mediated proteasomal degradation; however, overexpression of Pin1 failed to rescue WWP1-mediated downregulation of TAp63*α*(T538A), though T538A mutation abolished Pin1-mediated stabilization of wild-type TAp63*α* ([Figures 3b and c](#fig3){ref-type="fig"}), suggesting that this substitution removes the binding of Pin1, but not of WWP1, to this region. Further study demonstrated that Pin1 impairs TAp63*α*--WWP1 but not TAp63*α*(T538A)--WWP1 interaction: as shown in [Figure 4g](#fig4){ref-type="fig"}, though the amount of immunoprecipitated wild-type Myc-TAp63*α* from H1299:Pin1 was much higher than that from H1299:Pin1(W34A), the amount of co-immunoprecipitated WWP1 was significantly lower than that from H1299:Pin1(W34A); at the same time, immunoprecipitation with Myc antibody yielded similar amounts of either Myc-TAp63*α*(T538A) or WWP1 from H1299:Pin1 and H1299:Pin1(W34A).

These data suggest that Pin1 protects TAp63*α* from degradation via binding to its phospho-Thr~538~-Pro peptidyl-prolyl bonds and impairing the binding of WWP1 to the P~540~PxY~543~ motif of TAp63*α*; T538A mutation in TAp63*α* abolishes the action of Pin1 on this site and it makes TAp63*α*(T538A) proteins vulnerable to WWP1-mediated degradation.

Pin1 enhances TAp63*α*-mediated transcription and apoptosis
-----------------------------------------------------------

To investigate whether the Pin1-mediated upregulation of TAp63*α* can stimulate transcription of its target genes, luciferase reporter assays were performed. Our results demonstrate that TAp63*α* upregulated the Bax-luc reporter activities ([Figure 5a](#fig5){ref-type="fig"}), which was further enhanced by Pin1 ([Figure 5b](#fig5){ref-type="fig"}) in a dose-dependent manner. In addition, TAp63*α* stimulated the expression of endogenous Puma, which was further enhanced by Pin1 ([Figures 5c and d](#fig5){ref-type="fig"}). These results suggest that Pin1 has a positive role in regulating expression of downstream target genes of TAp63*α*, consistent with the results from a previous report.^[@bib8]^

To examine the effect of Pin1 on TAp63*α*-mediated apoptosis, H1299 cells co-transfected with TAp63*α* and/or Pin1 were subjected to immunoblotting or flow cytometry (FCM) analysis. The immunoblotting results showed that TAp63*α* induced the cleavage of PARP1, which is a hallmark of apoptosis; wild-type Pin1, but not Pin1(W34A), further increases TAp63*α*-induced PARP1 cleavage ([Figure 5e](#fig5){ref-type="fig"}). FCM analysis further confirmed that wild-type Pin1, but not Pin1(W34A), promoted TAp63*α*-induced apoptosis ([Figure 5f](#fig5){ref-type="fig"} and [Supplementary Figure S4](#sup1){ref-type="supplementary-material"}).

Ablation of Pin1 decreases expression of ΔNp63*α*, leading to inhibition of cell proliferation
----------------------------------------------------------------------------------------------

Our above-mentioned results demonstrated that, like TAp63*α*, ΔNp63*α* is also stabilized by Pin1 ([Figures 2d, e, h](#fig2){ref-type="fig"}, and [4d](#fig4){ref-type="fig"}). To investigate whether the Pin1 effect on ΔNp63*α* regulates cell proliferation and tumorigenesis, we established stable FaDu cells with knockdown of Pin1 (shPin1), simultaneous knockdown of both Pin1 and WWP1 (shPin1/shWWP1), or overexpression of ΔNp63*α* in Pin1-knockdown cells (shPin1/ΔNp63*α*). As shown in [Figure 6a](#fig6){ref-type="fig"}, knockdown of Pin1 in FaDu cells decreased ΔNp63*α* (lane 2 *versus* lane 1), which was rescued by simultaneous knockdown of WWP1 (lane 3 *versus* lane 2). Notably, shPin1/ΔNp63*α* cells did not yield much higher protein levels of ΔNp63*α* than control cells ([Figure 6a](#fig6){ref-type="fig"}, lane 4 *versus* lane 1). This might be because Pin1 knockdown made both endogenous and exogenous ΔNp63*α* vulnerable to WWP1-mediated proteasomal degradation. Importantly, Pin1 knockdown led to significant decrease in cell proliferation, as shown by cell doubling time ([Figure 6b](#fig6){ref-type="fig"}) as well as FCM analysis ([Figures 6c and d](#fig6){ref-type="fig"}); simultaneous knockdown of WWP1 largely rescued proliferation defect induced by knockdown of Pin1 ([Figures 6b--d](#fig6){ref-type="fig"}). Furthermore, ectopic expression of ΔNp63*α* similar to knockdown of WWP1, was able to dramatically rescue inhibition of proliferation induced by Pin1 knockdown ([Figures 6b--d](#fig6){ref-type="fig"}). These data suggest that Pin1-mediated modulation of ΔNp63*α* has an important role in cell proliferation.

Pin1-mediated stabilization of ΔNp63*α* has important roles in tumorigenesis
----------------------------------------------------------------------------

To investigate whether Pin1-mediated stabilization of ΔNp63*α* affects cell proliferation *in vivo*, we monitored tumor formation derived from FaDu cells in nude mice. The results showed that control FaDu cells can develop observable tumors, while ablation of Pin1 (FaDu:shPin1) led to dramatically reduced tumor formation ([Figures 7a--c](#fig7){ref-type="fig"}). Importantly, simultaneous knockdown of both Pin1 and WWP1 (FaDu:shPin1/shWWP1) led to tumor formation much faster than FaDu:shPin1, although slower than controls ([Figures 7a--c](#fig7){ref-type="fig"}). In addition, ectopic expression of ΔNp63*α* could also rescue the tumor growth defect resulted from Pin1 knockdown ([Figures 7a--c](#fig7){ref-type="fig"}). These data suggest that Pin1 is critical for tumor formation *in vivo*, at least in part, through the WWP1-ΔNp63*α* pathway.

It has been shown that ΔNp63*α* is overexpressed in approximately 60% of oral squamous cell carcinoma (OSCC).^[@bib14]^ To investigate whether Pin1-ΔNp63*α* pathway has a clinical relevance, we examined the protein expression by immunoblotting with OSCC tumor tissues and paracancerous normal controls. As shown in [Figure 7d](#fig7){ref-type="fig"} and [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}, compared with their paracancerous normal controls (indicated as the horizontal line), protein levels of ΔNp63*α* and Pin1 were simultaneously elevated in 5 (1\#, 3\#, 6\#, 8\#, 12\#) out of 12 OSCC patients. These data suggest that overexpression of Pin1 may have a role in stabilizing ΔNp63*α* in OSCC cells, that may contribute, in part, to the etiology of tumor development.

Discussion
==========

p63 has been reported to have important roles in cell survival, proliferation, tumorigenesis, and development.^[@bib2],\ [@bib15]^ Even though accumulating evidence indicates that posttranslational regulation of p63 is important in control of p63 activity, how p63 protein stability is regulated remains still largely unclear. In this study, we show that peptidyl-prolyl isomerase Pin1 is an important regulator of p63. We found that Pin1 directly binds to p63 and disrupts p63*α*--WWP1 interaction, resulting in p63*α* protein stabilization. In addition, we show that Pin1 enhances TAp63*α*-mediated apoptosis and promotes ΔNp63*α*-mediated cell proliferation (as depicted in [Figure 8](#fig8){ref-type="fig"}). Furthermore, knockdown of Pin1 in FaDu cells inhibits tumor formation in nude mice, which is significantly rescued by simultaneous knockdown of WWP1 or ectopic expression of ΔNp63*α*. Moreover, overexpression of Pin1 correlates with increased expression of ΔNp63*α* in human oral squamous cell carcinoma samples.

TAp63*α* contains 14 putative Pin1-binding sites, 8 of which are included in all of p63 proteins isoforms; there are 6 putative Pin1-binding sites in the unique C-terminal regions of *α* isoforms (as depicted in [Figure 3a](#fig3){ref-type="fig"}). Although the physical interaction between p63 and Pin1 was previously reported, the underlying mechanism and biological effects of Pin1--p63 direct interaction remain unclear.^[@bib8]^ Our data show that Pin1 interacts with p63 proteins, including TA*α*, ΔN*α*, TA*γ* and ΔN*γ* isoforms. However, Pin1 specially stabilizes *α* isoforms, but not *γ* isoforms, indicating that these six Pin1-binding sites in the C-terminal region may have critical roles for protein stability of p63*α* isoforms. Although *β* isoforms have not been investigated in this work, we speculate that TAp63*β* and ΔNp63*β* can also be stabilized by Pin1, since they also contain the same TPPPxY sequence with p63*α* isoforms.

We further identified that T~538~ in TAp63*α* is critical for Pin1-mediated stabilization of p63*α* isoforms. Notably, T~538~ is adjacent to the WWP1 binding site (P~540~PxY~543~), and WWP1 has been reported to target its substrate proteins, including p63*α*, for proteasome-dependent degradation.^[@bib12]^ Our data indicate that Pin1 inhibits the binding of WWP1 to p63*α*, likely because the isomerization resulted from the Pin1--p63 interaction affects the cyclization of the region encompassing PPxY motif of p63, which is important for the binding of WW domain of E3 ligases.^[@bib16],\ [@bib17]^ It is also possible that the binding of Pin1 to phospho-Thr~538~-Pro interferes with WWP1--p63*α* interaction, since both of them bind to p63 via their WW domains.^[@bib12]^ Notably, since the E3 ligase Itch also binds to the same PPxY motif,^[@bib16],\ [@bib17],\ [@bib18]^ it is plausible that Pin1 may also affect p63--Itch interaction. Moreover, it has been reported that ΔNp63*α* can also undergo a proteasomal degradation pathway coordinately mediated by MDM2 and Fbw7 in HaCaT and U2OS cells;^[@bib19]^ it has been also documented that Pin1 can negatively regulate Fbw7 in human colon cancers and some cell lines including HCT116 and HeLa.^[@bib20]^ Therefore, Pin1 may protect p63 proteins from proteasomal degradation mediated by MDM2/Fbw7. Our data suggest that Itch or MDM2/Fbw7 are unlikely to have major roles in Pin1-mediated p63*α* stabilization in our experiment system, since the decrease in p63*α* protein levels mediated by Pin1 knockdown is almost completely rescued by simultaneous knockdown of WWP1.

Though endogenous TAp63 proteins are barely detectable in somatic cells,^[@bib21]^ overexpression of TAp63 proteins promotes cell cycle arrest and apoptotic cell death via activating p53 pro-apoptotic targets, such as Puma, Bax and Noxa.^[@bib22],\ [@bib23],\ [@bib24]^ Animal studies reveal that TAp63 induces senescence and suppress tumorigenesis and metastasis *in vivo*.^[@bib25],\ [@bib26]^ In oocytes, TAp63*α* is responsible for DNA damage-induced apoptosis, therefore functioning as a quality control factor in the female germline.^[@bib27],\ [@bib28]^ Together, these studies indicate that TAp63 functions to promote apoptosis. In this study, we show that Pin1 enhances TAp63*α* protein stability, thereby stimulating TAp63*α*-mediated gene expression, including Puma, and leading to enhanced apoptosis.

In contrast to the tumor suppressor activity of TAp63, ΔNp63 proteins inhibit apoptosis and promote cell proliferation via antagonizing transcriptional activities of p53, TAp63 and TAp73 proteins.^[@bib2]^ In the present work, we show that Pin1 reduces tumorigenicity of FaDu cells in xenograft animal models, indicating that Pin1 possesses strong oncogenic activity. FaDu is a human squamous carcinoma cell line, which expresses predominantly ΔNp63*α*. Our data indicate that knockdown of Pin1 leads to significant decrease in ΔNp63*α* protein level. Restoration of ΔNp63*α* protein levels, either by simultaneous knockdown of WWP1 or ectopic expression of ΔNp63*α*, significantly confers the tumor formation potential of the FaDu cells, indicating that the Pin1-WWP1-ΔNp63*α* pathway has important role in tumor development. Consistent with this notion, analysis of clinical samples reveals positive correlation of Pin1 and ΔNp63*α* expression in human oral squamous cell carcinoma. Although the amplification and transcription of p63 gene may contribute to p63 protein abundance in squamous cell carcinoma,^[@bib29]^ Pin1 likely has some role in p63*α* stability, since both p63*α* and Pin1 proteins were readily detected in the clinical samples. Together, these studies suggest that Pin1-ΔNp63*α* pathway may be critical for development of human squamous carcinoma.

It was recently reported that Pin1 promotes mutant p53-dependent inhibition of the p63 function via potentiating the complex formed by Smad2, p63 and mutant p53 and downregulating p63 anti-metastatic target genes.^[@bib8]^ In this work, we demonstrate that Pin1 can stabilize both TAp63*α* and ΔNp63*α* proteins, which functions as either a tumor suppressor or an oncoprotein, respectively (as depicted in [Figure 8](#fig8){ref-type="fig"}). Accumulating evidence indicates that Pin1 may exhibit tumor suppressor activity by positively regulating p53 and TAp73.^[@bib9],\ [@bib10],\ [@bib11],\ [@bib30]^ On the other hand, Pin1 is upregulated in human tumors and may promote tumorigenesis via activating oncoproteins such as mutant p53 or inactivating tumor suppressors such as Rb.^[@bib8],\ [@bib20],\ [@bib31],\ [@bib32],\ [@bib33]^ In a given cell, the net effect of Pin1 may depend on the ratio of tumor suppressors (such as TAp63*α*) to oncoproteins (such as ΔNp63*α*) regulated by Pin1. Given the fact that ΔNp63*α* is the predominant p63 isoform and is overexpressed in human squamous carcinoma, our study suggests that Pin1 functions as an oncoprotein via activating ΔNp63*α* which may have important roles in certain tumor formation.

Materials and Methods
=====================

Constructs and siRNAs
---------------------

Constructs of p63, Pin1 and Bax-luc reporters were previously described.^[@bib34],\ [@bib35],\ [@bib36]^ The full-length human WWP1 cDNA was cloned into pCMV (Clontech, New York City, NY, USA). Pin1 shRNA sequence (TGCTGTTGACAGTGAGCGAAGGCCGAGTGTACTACTTCAATAGTGAAGCCACAGATGTATTGAAGTAGTACACTCGGCCTGTGCCTACTGCCTCGG) was cloned into pLKO.1 (Clontech). The construct of shWWP1 was purchased from Thermo Open Biosystem (Pittsburgh, PA, USA; target sequence: ATTGCTTATGAACGCGGCTTT).^[@bib37]^ Small interference RNAs (siRNAs) were synthesized by GenePharma (Shanghai, China). The target sequences are as below: siWWP1, GCAGAGAAATACTGTTTAT;^[@bib12]^ siPin1, GCCATTTGAAGACGCCTCG.^[@bib38]^ The specific siRNAs or scrambled controls were transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer\'s instructions.

Cell culture, transfection and lentiviral infection
---------------------------------------------------

Cell culture and lentiviral infection were performed as described previously.^[@bib34]^ Transient transfection was performed with Lipofectamin2000 (Invitrogen), and total amounts of plasmid DNA were balanced with corresponding vectors. H1299:Pin1, H1299:Pin1(W34A) and HEK:ΔNp63*α* cells were screened with 2 *μ*g/ml puromycin. To generate FaDu:shPin1, FaDu:shPin1/shWWP1 and FaDu:shPin1/ΔNp63*α* cells, FaDu cells were infected with shPin1, shWWP1 or ΔNp63*α* lentiviral particles sequentially, and screened with 2 *μ*g/ml puromycin.

For growth curve analysis, cells tranfected with indicated genes were trypsinized and reseeded into 12-well plate at a density of 10 000 cells per well in triplicate. In the following 3 days, cells were trypsinized and counted at indicated time points.

Pull-down, immunoprecipitation and immunoblotting analysis
----------------------------------------------------------

GST-fused wild-type and mutant Pin1 proteins were expressed and subjected to pull-down assay as described previously.^[@bib35]^ In brief, H1299 cells were transfected with expression plasmids of different p63 isoforms for 24 h and then lysed in EBC150 buffer containing 10% glycerol. A total of 500 *μ*g of total proteins were subjected to GST pull-down assay with GST alone. The pull-down products or input samples were separated by 10% SDS-PAGE. Immunoblotting analysis (IB) was performed using indicated specific antibodies.

Immunoprecipitation (IP) and immunoblotting (IB) analysis were performed as previously described.^[@bib11],\ [@bib34]^ Antibodies used were specific for p63 (4A4 monoclonal antibody, Santa Cruz, Dallas, TX, USA, 1 : 200), myc (9E10 monoclonal antibody, Santa Cruz, 1 : 1000), Pin1 (rabbit polyclonal antibody, Cell Signaling, Danvers, MA, USA, 1 : 1000), actin (rabbit polyclonal antibody, Santa Cruz, 1 : 1000), HA (mouse monoclonal antibody, Millipore, Billerica, MA, USA, 1 : 500), WWP1 (rabbit monoclonal antibody, Epitomics, Burlingame, CA, USA, 1 : 3000), Puma (rabbit polyclonal antibody, Santa Cruz, 1 : 1000), and N-terminal cleaved PARP1 (rabbit polyclonal antibodies, Zenable, Chengdu, China, 1 : 8000).

Luciferase reporter, flow cytometry and protein stability assays
----------------------------------------------------------------

Luciferase reporter assay was performed with Dual-Luciferase Reporter (DLR) Assay System (Promega, Fitchburg, WI, USA) according to the manufacturer\'s instructions. Flow cytometry (FCM) and protein stability assay was performed as described previously.^[@bib34]^

Xenograft experiments
---------------------

Male SCID mice in a BALB/C background, at an age of 8--10 weeks at the time of inoculation, were used to establish xenografts. Cells (2 × 10^6^/0.1 ml) were subcutaneously inoculated into the right flank of each nude mice. The volumes of xenograft were measured 15, 20, 22, and 24 days after inoculation. The tumor volumes were calculated according to the formula:volume=length × width^[@bib2]^. The xenografts were dissected and weights were measured 24 days after inoculation.

Human oral squamous cell carcinoma samples
------------------------------------------

Human specimens of oral squamous cell carcinoma and paracancerous tissues were dissected from patients at surgery. Tissues were stored in liquid nitrogen until processing. For immunoblotting analysis, the tissues were ground in liquid nitrogen and lysed with radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-Cl pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, plus 5 mM EDTA, 1 mM NaF, 1 mM sodium orthovanadate, and protease inhibitors).

Quantification and statistical analysis
---------------------------------------

Intensities of protein bands were quantified with Image Lab (Bio-Rad, Berkeley, CA, USA) and relative intensities were normalized with actin. Data were shown as means±standard deviations (S.D.). *P*-values were calculated using the Student\'s *t* test.
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![p63 proteins physically interact with Pin1. (**a**) and (**b**) Pin1 interacts with TAp63 *in vitro*. H1299 cells transfected with either TAp63*α* or TAp63*γ* expression plasmid were lysed and subjected to GST pull-down assay with GST alone (lane 2) or GST--Pin1 (lane 3). 10 *μ*g of total protein from the same cell lysates were directly loaded as input controls (lane 1). Immunoblotting analysis (IB) was performed using an antibody specific for p63 (4A4, *α*-p63; top panels). Comparable amounts of GST and GST--Pin1 fusion proteins were shown by staining the membrane with Coomassie blue R-250 (bottom panels). (**c**) Pin1 interacts with ΔNp63 *in vitro*. Pull-down experiments were performed as described above. 10 *μ*g of total protein from lysate inputs (top panel) and pull-down products (bottom panel) were subjected to IB analysis with *α*-p63. (**d**) The WW domain of Pin1 mediates Pin1--p63 interaction, which can be abolished by W34A or Y23A point mutation in the WW domain of Pin1. GST pull-down experiments were performed with GST alone (lane 2), GST--Pin1 (lane 3), GST--PPIase (lane 4), GST--WW (lane 5), GST--Pin1 (W34A) (lane 6) or GST--Pin1 (Y23A) (lane 7). (**e**) Wild-type but not W34A mutant Pin1 can form a stable complex with TAp63*α*. Lysates from H1299 cells transiently expressing HA-tagged wild-type or W34A mutant Pin1 were subjected to immunoprecipitation (IP) and IB using myc or HA antibody. (**f**) Endogenous proteins of ΔNp63*α* and Pin1 form a stable complex in FaDu cells. 2 mg of FaDu cell lysate was subjected to IP with *α*-p63 (4A4) or IgG control. The IP products were subjected to IB with *α*-p63 or *α*-Pin1](cddis2013468f1){#fig1}

![Pin1 upregulates protein levels of p63*α*, but not p63*γ*, via increasing their half-lives. (**a**) Transient overexpression of wild-type but not W34A mutant Pin1, upregulates the protein level of TAp63*α* in H1299 cells. 1 *μ*g HA-tagged wild-type or W34A mutant Pin1 expression plasmid, or vector control, was transfected together with 200 ng myc-tagged TAp63*α* expression plasmid and 50 ng pEGFP-N1, into H1299 cells. 48 h after transfection, cells were lysed and subjected to IB. (**b**) Transient overexpression of wild-type but not W34A mutant Pin1, upregulates the protein level of ΔNp63*α* in HEK293 cells. 1 *μ*g HA-tagged wild-type or W34A mutant Pin1 expression plasmid, or vector control, was transfected into a HEK293 cell line stably overexpressing ΔNp63*α* HEK293:ΔNp63*α*. Forty-eight hours after transfection, cells were lysed and subjected to IB analysis. (**c**) and (**d**) Stable expression of wild-type Pin1 upregulates protein levels of TAp63*α* and ΔNp63*α*, but not TAp63*γ* or ΔNp63*γ*. TA*α*, ΔN*α*, TA*γ* and ΔN*γ* isoforms of p63 expression plasmids (200 ng each) were respectively co-transfected with 50 ng pEGFP-N1 into H1299 cells stably expressing wild-type (H1299:Pin1) or W34A mutant \[H1299:Pin1(W34A)\] Pin1. Forty-eight hours after transfection, cells were lysed and subjected to IB analysis. (**e**) SiRNA-mediated knockdown of Pin1 downregulates protein levels of ΔNp63*α* in HEK293 cells. SiPin1 or scrambled control (20 pmol each) was transiently transfected into HEK293 cells stably overexpressing ΔNp63*α*. Forty-eight hours after transfection, cells were lysed and subjected to IB analysis. (**f**) and (**g**) Pin1 extends protein half-life of TAp63*α*. H1299 cells were co-transfected with TAp63*α* (200 ng) and pEGFP-N1 (50 ng), together with HA-Pin1 (400 ng) or its vector control, for 24 h and then treated with 50 mg/ml cycloheximide (CHX) for indicated durations followed by IB analysis (**f**). Protein levels of TAp63*α* were normalized with Actin, and the protein half-life was quantified (**g**). (**h**) and (**i**) Pin1 extends protein half-life of ΔNp63*α*. HEK293:ΔNp63*α* cells were transfected with HA-Pin1 (1 *μ*g) or its vector control for 24 h and then treated with 50 mg/ml cycloheximide (CHX) for indicated durations followed by IB analysis (**h**). The half-life of ΔNp63*α* proteins was quantified (**i**)](cddis2013468f2){#fig2}

![T538A point mutation abrogates Pin1-mediated upregulation and siPin1-mediated downregulation of TAp63*α*. (**a**) Schematic representation of putative Pin1-binding sites in different p63 isoforms. TAD, transactivation domain; DBD, DNA-binding domain; OLD, oligomerization domain; SAM, sterile alpha motif; TID, trans-inhibitory domain. Dots indicate putative Pin1-binding sites, which are Serine-Proline (SP) or Threonine-Proline (TP) motifs. A PPxY motif (framed letters) is adjacent to the T538-P in TAp63*α* or the T444-P in ΔNp63*α*. (**b**) T538A, but not other point mutations of putative Pin1-binding sites in the special C-terminus of TAp63*α*, abrogates the Pin1-mediated upregulation of TAp63*α*. S463A, T491A, T538A, or T619A mutant, or wild-type TAp63*α* plasmid (200 ng each) was co-transfected pEGFP-N1 (50 ng) into H1299:Pin1(W34A) or H1299:Pin1 cells. Forty-eight hours after transfection, cells were lysed and subjected to immunoblotting analysis. The relative level of each mutant TAp63*α* in Pin1(W34A) control was respectively set as 1.0. (**c**) SiRNA-mediated knockdown of Pin1 downregulates wild-type but not T538A mutant TAp63*α* Pin1 siRNA (siPin1) or scrambled control (20 pmol each) was transiently co-transfected into H1299 cells with expression plasmid of wild-type (WT) or T538A mutant TAp63*α* (1 *μ*g each), together with 50 ng pEGFP-N1. Forty-eight hours after transfection, cells were lysed and subjected to immunoblotting analysis. The relative level of wild-type or T538A mutant TAp63*α* in scrambled control was respectively set as 1.0](cddis2013468f3){#fig3}

![Pin1 inhibits proteasome- and WWP1- dependent degradation of p63*α* proteins. (**a**) MG132 abrogates Pin1-mediated upregulation of TAp63*α* H1299:Pin1 or H1299:Pin1(W34A) cells were co-transfected with TAp63*α* (400 ng) and pEGFP-N1 (50 ng) for 24 h. Cells were then treated with 40 *μ*M MG132, which is a specific proteasome inhibitor, or its vehicle control (0.4% DMSO), for additional 18 h before collection. Cell lysates were subjected to immunoblotting analysis. (**b**) MG132 abrogates siPin1-mediated downregulation of TAp63*α* (400 ng). Pin1 siRNA (siPin1) or scrambled control (20 pmol each) was transiently co-transfected into H1299 cells with expression plasmid of TAp63*α* (1 *μ*g) and pEGFP-N1 (50 ng). Twenty-four hours later, cells were treated with 40 *μ*M MG132 or 0.4% DMSO for an additional 18 h. Then cells were collected and subjected to immunoblotting analysis. (**c**) WWP1 downregulates TAp63*α* while wild-type Pin1 can rescue this downregulation. TAp63*α* expression plasmid (400 ng) was co-transfected with WWP1 (200 ng) or (and) wild-type or W34A mutant HA-Pin1 (1 *μ*g) expression plasmids or their vector controls, together with pEGFP-N1 (50 ng). Forty-eight hours after transfection, cells were collected for immunoblotting analysis. (**d**) WWP1 downregulates ΔNp63*α* while Pin1 can rescue this downregulation. WWP1 (200 ng) or (and) HA-Pin1 (1 *μ*g) expression plasmids or their vector controls were co-transfected into HEK293 cells stably overexpressing ΔNp63*α* (HEK293:ΔNp63*α*). Forty-eight hours after transfection, cells were collected for immunoblotting analysis. (**e**) Knockdown of WWP1 upregulates TAp63*α* and removes the siPin1-mediated downregulation of TAp63*α*. SiPin1 and (or) siWWP1 (20 pmol each) were co-transfected into H1299 cells together with TAp63*α* (500 ng) and pEGFP-N1 (50 ng). Forty-eight hours after transfection, cells were collected for immunoblotting analysis. (**f**) WWP1 downregulates T538A mutant TAp63*α* but Pin1 cannot rescue this downregulation. T538A mutant TAp63*α* expression plasmid (400 ng) was co-transfected with WWP1 (200 ng) or (and) HA-Pin1 (1 *μ*g) expression plasmids or its vector control, together with pEGFP-N1 (50 ng). Forty-eight hours after transfection, cells were collected for immunoblotting analysis. (**g**) Pin1 impairs the binding of WWP1 to wild-type but not T538A mutant TAp63*α*. 0.5 *μ*g wild-type or T538A mutant Myc-TAp63*α* plasmid was transfected into H1299:Pin1(W34A) or H1299:Pin1 cells, together with 0.5 *μ*g WWP1 expression plasmid. Twenty-four hours after transfection, cells were lysed and 1 mg total protein samples were respectively subjected to immunoprecipitation with myc antibody (*α*-myc). The IP products were subjected to immunoblotting analysis](cddis2013468f4){#fig4}

![Pin1 enhances TAp63*α*-mediated transcription and cell apoptosis. (**a**) TAp63*α* upregulates the expression of Bax-luc reporter in a dose-dependent manner. H1299 cells were co-transfected with 500 ng of Bax-luc reporter, 50 ng pCMV-Renilla reporter and increasing amounts of TAp63*α* expression plasmid (0, 20, 50, and 100 ng). Twenty-four hours post-transfection, the cells were lysed and Bax-luc and Renilla activities were measured. Immunoblotting analysis was performed to detect the expression of TAp63*α*. The Bax-Luc activity was normalized to Renilla activity and presented as fold activation with standard deviation (*n*=3). (**b**) Pin1 upregulates TAp63*α*-mediated Bax-luc expression in a dose-dependent manner. H1299 cells were co-transfected with 500 ng of Bax-luc reporter, 50 ng pCMV-Renilla reporter, 20 ng TAp63*α* expression plasmid and an increasing amount of pcDNA3.1-HA-Pin1 (0, 100, 200, and 5 ng). Twenty-four hours post-transfection, luciferase and Renilla activities were measured. The Bax-Luc activity was normalized to Renilla activity and presented as fold activation with standard deviation (*n*=3). Immunoblotting analysis was performed to detect the expression of TAp63*α* and Pin1. (**c**) Pin1 upregulates TAp63*α*-mediated expression of endogenous Puma. H1299:Pin1 or H1299:Pin1(W34A) cells were transfected with TAp63*α* or its vector control (200 ng). Forty-eight hours post-transfection, cells were lysed and subjected to immunoblotting analysis. The intensities of Puma bands were normalized with Actin. (**d**) Pin1 upregulates TAp63*α* and endogenous Puma in a dose-dependent manner. H1299 cells were transfected with fixed dose of TAp63*α* plasmid (100 ng), together with an increasing amount of pcDNA3.1-HA-Pin1 (0, 200, 500 and 1000 ng). Forty-eight hours post-transfection, the cells were lysed and subjected to immunoblotting analysis with indicated antibodies. The intensities of Puma bands were normalized with Actin. (**e**) and (**f**) Pin1 augments TAp63*α*-induced cell apoptosis. TAp63*α* (400 ng) was co-transfected with HA-Pin1 or HA-Pin1(W34A) (1600 ng) into H1299 cells in a 6-well plate. Twenty-four hours after transfection, cells were trypsinized and subjected to immunoblotting analysis (**e**) or flow cytometry analysis of apoptosis (**f** and [Supplementary Figure S4](#sup1){ref-type="supplementary-material"})](cddis2013468f5){#fig5}

![Pin1 knockdown inhibits cell proliferation via decreasing ΔNp63*α* protein levels. (**a**) Pin1 and WWP1 modulate the protein level of ΔNp63*α* in FaDu cells. FaDu cells were infected with shPin1, shWWP1 or ΔNp63*α* lentiviral particles sequentially, and screened with 2.5 *μ*g/ml puromycin. Parts of cells were collected and lysed for immunoblotting analysis. (**b**) Pin1 knockdown induces inhibition of cell proliferation, which is rescued by simultaneous knockdown of WWP1 or overexpression of ΔNp63*α*. Stable FaDu cells mentioned above were seeded into 12-well plate at a density of 10 000 cells per well in triplicate. Cells were trypsinized and counted at indicated time points. (**c**) and (**d**) Pin1 knockdown induces G1 arrest of cell cycle, which is rescued by simultaneous knockdown of WWP1 or overexpression of ΔNp63*α*. Stable FaDu cells mentioned above were subjected to flow cytometry analysis (**c**), and percentages of cells in each phase were analyzed (**d**)](cddis2013468f6){#fig6}

![Pin1-mediated stabilization of ΔNp63*α* has important roles in tumorigenesis. (**a**)--(**c**) Pin1 knockdown induces growth inhibition of xenograft, which is rescued by simultaneous knockdown of WWP1 or ectopic expression of ΔNp63*α*. Stable FaDu cells mentioned above (2 × 10^6^/0.1 ml) were subcutaneously inoculated into the right flank of each nude mice (*n*=5). The volumes of xenografts were measured 15, 20, 22, and 24 days after inoculation (**a**). The xenograft tumors dissected at day 24 were imaged (**b**) and weighed (**c**). \*\**P*\<0.01. (**d**) Protein levels of ΔNp63*α* and Pin1 were correlated in oral squamous cell carcinoma (OSCC). Lysates of OSCC tumor tissues or paracancerous normal controls were subjected to immunoblotting analysis (shown as [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). Expression levels of ΔNp63*α* and Pin1 were normalized with actin, and ratio of either ΔNp63*α* or Pin1 in each paracancerous normal control was respectively set as 1.0 and indicated as the horizontal line](cddis2013468f7){#fig7}

![Schematic model of a proposed mechanism showing how Pin1--p63*α* pathway modulates cell survival/proliferation. TAp63*α* and ΔNp63*α* undergo a proteasomal degradation mediated by E3 ligase WWP1. However, Pin1 may mediate the *cis-trans* isomerization or physical occupation of pTP-PPxY motifs of p63*α* proteins, leading to impairing their binding to WWP1. Consequently, TAp63*α* or ΔNp63*α* was stabilized. As a result, Pin1 inhibits cell survival/proliferation via stabilizing TAp63*α* or promotes cell survival/proliferation via stabilizing ΔNp63*α*](cddis2013468f8){#fig8}
